Funded Tech Companies
HiberCell
HiberCell, operating out of New York, received investment capital from Mount Sinai Ventures, Bristol-Myers Squibb and Trinitas Capital.
Company Overview
Company Name
HiberCell
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
619 West 54th St. 8th Floor
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Website
Email Address
Company Background Information
Overview
HiberCell is the first company exclusively focused on tumor dormancy detection and therapeutics. The company is developing first-in-class therapeutics that target dormant disseminated tumor cells (DTCs) from solid and liquid cancers, with the ultimate goal of preventing cancer relapse and metastasis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/20/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Financial Officer
Joseph Talamo
President
Alan Rigby
Vice President
Nandita Bose
Vice President
Michele Gargano
Vice President
Mark Mulvihill
Vice President
Patricia Oliver
Vice President
Savi Ramurthy
Vice President
David Surguladze
VP - Bus. Development
Ari Nowacek
Company Investors
- Mount Sinai Ventures
- Bristol-Myers Squibb
- Trinitas Capital
- Tekla Capital Management
- Magnetic Ventures
- Arch Venture Partners (Ari Nowacek)
- Hercules Technology Growth Capital
- Monashee Investment Management (Rene Mora)
- Huizenga Capital Management
- Celgene
- 6 Dimensions Capital
- Hillhouse Capital Group
- LifeSci NYC
Browse more funded tech companies:
HiBeam Internet & Voice | Hiberna
Share this article
About Our Venture Capital Transactions Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs